DV
Dividend Vision

GPCR — Structure Therapeutics Inc.

Structure Therapeutics Inc. (GPCR)

Total return is 263.4% over the past 3.5 years, 168.6 points ahead of SPY at 94.8%. Its deepest 1-year drawdown was 61.7%.

This is a single-stock equity holding in Structure Therapeutics Inc., a biotechnology company focused on drug development. The holding generates no dividend distributions and carries no expense ratio as it represents direct stock ownership rather than a traditional ETF structure. This holding appeals to growth-oriented investors seeking exposure to the biotech sector, though it lacks the income component typical of dividend-focused strategies.

GPCR key facts

Asset type
Stock
Asset class
Equity
Inception date
02/02/2023
Distribution frequency
None
Last close
$54.51
Market cap
$3,874,271,488
Average volume
555889.0
Beta
-1.507
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.03